首页> 外文期刊>Hawaii medical journal >Cationic Lipsomes Promote in Vivo Transfection, Innate Immunity Activation and Antigen-Specific CD8+ T-Cell Activation Following Vaccination with Piggybac DNA Plasmids
【24h】

Cationic Lipsomes Promote in Vivo Transfection, Innate Immunity Activation and Antigen-Specific CD8+ T-Cell Activation Following Vaccination with Piggybac DNA Plasmids

机译:接种Piggybac DNA质粒后,阳离子脂质体可促进体内转染,先天免疫激活和抗原特异性CD8 + T细胞激活。

获取原文
       

摘要

DNA vaccination with plasmid has conventionally involved vectors designed for transient expression of antigen in injected tissues. Next generation plasmids are being developed for site-directed integration of transgenes into safe sites in host genomes and may provide an innovative approach for stable and sustained expression of antigens for vaccination. In our previous study, we have demonstrated the improved efficacy of site-directed integration using hyperactive piggyBac transposase-based integrating vectors (pmhyGENIE-3) over non-integrating plasmids. Adjuvant technologies such as AdjuplexTM may further improve vaccine efficacy by producing a strong immunostimulatory effect to elicit more potent immune responses via both cell-mediated and antibody-mediated mechanisms.
机译:质粒的DNA疫苗接种通常涉及用于在注射组织中瞬时表达抗原的载体。正在开发下一代质粒,用于将转基因定点整合到宿主基因组中的安全位点中,并可能提供一种创新的方法来稳定,持续表达用于疫苗的抗原。在我们以前的研究中,我们已经证明了使用基于hyperpiggyBac转座酶的整合载体(pmhyGENIE-3)进行定点整合的效果优于非整合质粒。佐剂技术(例如AdjuplexTM)可通过产生强大的免疫刺激作用,通过细胞介导的机制和抗体介导的机制引发更有效的免疫反应,从而进一步提高疫苗效力。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号